Results 21 to 30 of about 6,974,500 (303)
Neurological comorbidity and severity of COVID-19 [PDF]
Journal of Neurology, 2020 Abstract Objective Neurological symptoms of COVID-19 patients have been recently described. However, no comprehensive data have been reported on pre-existing neurological comorbidities and COVID-19. This study aims at evaluating the prevalence of neurological comorbidities, and their association with COVID-19 severity.
Romagnolo A. +13 more
openaire +4 more sources
Malawi: The impact of COVID-19 and food system responses
, 2021 Malawi, like other southern African countries, has endured several waves of infection since the COVID-19 pandemic started. The disease has had severe effects on the economy, including the agriculture sector.
COVID-19 Hub
core +1 more source
Severe Acute Hepatitis in a COVID‐19 patient: A Case Report
Clinical Case Reports, 2021 Liver enzymes abnormalities are one of the reported presentations of coronavirus infection mostly in hospitalized patients. It is important that physicians take all the possible causes of acute hepatitis in consideration when dealing with abnormal liver ...
Shakiba Dehghani, Azam Teimouri
doaj +1 more source
Acute thyroid swelling with severe hypothyroid myxoedema after COVID‐19 vaccination
Clinical Case Reports, 2021 The SARS‐CoV‐2 virus can trigger thyroid dysfunction. Thyroid dysfunctions after COVID‐19 vaccination have been rarely reported. We report the case of overt hypothyroidism in a 61‐year‐old woman seen after BNT162b2‐mRNA vaccination.
Massimo Giusti, Agostino Maio
doaj +1 more source
Infant case of severe immune thrombocytopenia caused by COVID‐19 infection
eJHaem, 2023 Immune thrombocytopenia (ITP) is a common childhood acute autoimmune bleeding disorder caused by numerous viruses and characterized by isolated thrombocytopenia.
Tatsuya Anzai +6 more
doaj +1 more source
Air pollution and COVID-19 severity
European Respiratory Journal, 2023 Air pollution abatement would be a very effective way to protect our population from the impact of COVID-19 https://bit.ly ...
Jordi Sunyer, Payam Dadvand
openaire +3 more sources
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
Skin Health and Disease, 2023 Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination.
Ya‐ting Liu, Shang‐shang Wang
doaj +1 more source
The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis
Viruses, 2023 Severe COVID-19 is a major cause of morbidity and mortality worldwide, especially among those with co-morbidities, the elderly, and the immunocompromised.
Jia Soon Len +2 more
doaj +1 more source
Severe thrombocytopaenia secondary to COVID-19 [PDF]
BMJ Case Reports, 2020 The SARS-CoV-2 infection has caused a pandemic with a case rate of over 290 000 lab-confirmed cases and over 40 000 deaths in the UK. There is little evidence to inform the optimal management of a patient presenting with new or relapsed acute idiopathic thrombocytopaenic purpura with concurrent SARS-CoV-2 infection.
Patel, Trupesh +3 more
openaire +2 more sources
Proteinuria as a Biomarker for COVID-19 Severity [PDF]
Frontiers in Physiology, 2021 BackgroundRenal involvement in syndrome coronavirus 2 (SARS-CoV-2) infection has been retrospectively described, especially acute kidney injury (AKI). However, quantitative proteinuria assessment and its implication in coronavirus disease 2019 (COVID-19) remain unknown.MethodsIn this prospective, multicenter study in France, we collected clinical and ...
Hajar Ouahmi +17 more
openaire +3 more sources